Brief: Moonlake Immunotherapeutics AG And Helix Acquisition Corp. Announce Business Combination Agreement

MoonLake Immunotherapeutics

04/10/2021 12:56

Oct 4 (Reuters) - Helix Acquisition Corp.  HLXA.O :
    * MOONLAKE IMMUNOTHERAPEUTICS AG AND HELIX ACQUISITION CORP.
ANNOUNCE BUSINESS COMBINATION AGREEMENT TO CREATE PUBLICLY
LISTED BIOTECHNOLOGY COMPANY ADVANCING TRI-SPECIFIC NANOBODY®
SONELOKIMAB
    * HELIX ACQUISITION CORP. - LEADING INSTITUTIONAL INVESTORS
COMMIT
$115 MILLION THROUGH A PIPE LED BY CORMORANT ASSET MANAGEMENT
    * HELIX ACQUISITION CORP. - TRANSACTION ALSO INCLUDES
COMMITMENTS
FOR A $115 MILLION PIPE AT $10.00 PER SHARE
    * HELIX ACQUISITION CORP. - UPON CLOSING OF BUSINESS
COMBINATION,
MOONLAKE WILL HAVE ACCESS TO APPROXIMATELY $230 MILLION IN CASH

Source text for Eikon:  ID:nBw9Fp5TMa 
Further company coverage:  HLXA.O